Nitto Denko Avecia Inc

BioNTech US Inc, based in Cambridge, MA, is a pioneering global immunotherapy company that focuses on developing innovative treatments aimed at combatting cancer, infectious diseases, and other serious health conditions. With its origins in Mainz, Germany, the company leverages a robust international network and a strong commitment to research and development to advance next-generation immunotherapies. Driven by scientific rigor and operational excellence, BioNTech is dedicated to unlocking the full potential of the immune system and enhancing the health of individuals worldwide. The company continually expands its global manufacturing capabilities to ensure equitable access to its innovative therapies. Generated from the website

Gritstone Oncology is a biotechnology company based in Cambridge, MA, that is dedicated to developing innovative immunotherapies for cancer and infectious diseases. Their approach involves harnessing the power of the patient's immune system to recognize and destroy tumors or virally infected cells, with a focus on T cell recognition and proliferation. Through their proprietary platforms, Gritstone has developed a portfolio of immunotherapies designed to activate and direct the immune system, offering new opportunities for more patients to benefit from immunotherapy. With a strong emphasis on personalized medicine, Gritstone is developing individualized cancer vaccines, known as GRANITE, that target neoantigens specific to each patient. They are also working on off-the-shelf immunotherapies, known as SLATE, which utilize shared neoantigens derived from driver mutations. In addition to their cancer vaccine programs, Gritstone is leveraging their core technologies to develop next-generation vaccines for infectious diseases, including a collaboration with Gilead Sciences to research and develop a vaccine-based immunotherapy for HIV infection. Their facilities in Pleasanton, CA, Emeryville, CA, and Cambridge, MA, house their manufacturing capabilities, research labs, and development teams.Generated from the website

Quiver Bioscience, formerly known as Q-State Biosciences, is a leading biotechnology company based in Cambridge, MA, dedicated to revolutionizing drug development for neurological diseases. With a decade of scientific advancements and cutting-edge technology, Quiver utilizes human disease models, artificial intelligence, and a state-of-the-art platform to discover and develop transformative medicines for patients living with brain disorders. Driven by their innovative approach, Quiver integrates scalable biology, advanced engineering, and surrogate models to identify novel therapeutic targets and candidate molecules. Their proprietary cellular models capture the complexities of human biology, while their lineup of technologies and instrumentation measures hundreds of properties associated with cellular function per neuron. Through their analytics algorithms, Quiver extracts data from individual cells to gain insights into disease states and optimize therapeutic candidates with greater translational potential.Generated from the website